IHI European HealthCare Incubator Network
Funds a pan-European industry-and-academia incubator network that re-grants up to EUR 2,000,000 each to early-stage healthcare startups.
The consortium itself does not do the underlying health R&D — it governs the Network, runs FSTP sub-calls, and mentors selected startups, with at least 75% of IHI JU funding plus industry in-kind contribution earmarked for third-party funding. This is a two-stage Research and Innovation Action: a 20-page short proposal by the first deadline, then a 50-page full proposal by the second, both funded …
This topic funds one consortium to build a European HealthCare Incubator Network linking public-sector incubators (academia, foundations) with pharma, medtech and biotech industry incubators. It wants the Network to run competitive open calls awarding milestone-based Financial Support to Third Parties (FSTP) to early-stage companies at technology readiness level 3-5, alongside mentorship, infrastructure access and an 'industry quality seal' for validated startups.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Horizon Europe Grants for Startups: A Founder Guide
A practical guide to Horizon Europe grants for startups, including EIC, consortia, eligibility, Funding & Tenders, TRL, budgets, and EU strategy.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsLetter of Support for Grant Applications: Template and Examples
Learn how to write and request a letter of support for a grant, with template structure, examples, reviewer logic, and common mistakes.
Find grantsGovernment Grants for Startups: What Deeptech Founders Should Know
A practical guide to government grants for startups, including Grants.gov, SBIR/STTR, state programs, eligibility, fit, timelines, and when to apply.
More from IHI JU
All grants from this funder →An AI Foundation Toxicology Model and Framework to Support Waiving a Second Species in Drug Safety Studies
🇨🇦IHI JU · European Union
Funds development of an AI toxicology model that lets drug developers waive costly second-species animal safety testing.
Decode the Immunoscience of age-related diseases
🇪🇺IHI JU · European Union
Funds a research consortium that studies why immune-mediated diseases behave differently when they first strike older adults and hunts for biomarkers to predict them.
AI-Powered Signal Detection in Pharmacovigilance
🇪🇺IHI JU · European Union
Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.
Boosting innovation for a better understanding of the determinants of health
🇪🇺IHI JU · European Union
Funds public-private research on the determinants of health, from prevention and early diagnosis to new vaccine strategies and disease-outbreak preparedness.
Boosting innovation for better assessment of the added value of innovative integrated healthcare solutions
🇪🇺IHI JU · European Union
Funds public-private research on new health technology assessment methods that value combined, integrated healthcare innovations fairly.
Boosting innovation for people-centred integrated healthcare solutions
🇪🇺IHI JU · European Union
Funds public-private research that makes integrated healthcare solutions feasible and better matched to what patients and citizens actually need.
Similar grants
Browse the directory →
European Partnership for Pandemic Preparedness (Phase 2)
🇪🇺European Commission · European Union
Funds the next phase of Europe’s pandemic-preparedness partnership, clinical networks and One Health research ecosystem.
Horizon Health: Rare Disease Partnership (ERDERA) Phase 2
🇪🇺European Commission · European Union
Funds rare-disease research calls, clinical trial networks and shared data for ERDERA's second phase — open only to the existing coordinator.
Horizon Health: Antibody Therapies for Emerging Viruses
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.
Horizon Health: Bio-printing for Regenerative Medicine
🇪🇺European Commission · European Union
Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.
Horizon Health: Flavivirus Antibody Therapies
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one Flavivirus.
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.